Filing Details

Accession Number:
0001209191-22-050954
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-21 19:59:45
Reporting Period:
2022-09-19
Accepted Time:
2022-09-21 19:59:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501756 Adverum Biotechnologies Inc. ADVM Biological Products, (No Disgnostic Substances) (2836) 205258327
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1736315 Peter Soparkar C/O Adverum Biotechnologies, Inc.
100 Cardinal Way
Redwood City CA 94063
See Remarks Section No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-19 13,305 $1.07 273,251 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
  2. Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.0728. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Includes 6,000 shares purchased on May 20, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.